arrow
T

Thomas A. Lanz

pfizer inc.
H指数:30
被引数:3,385

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Generation of cynomolgus monkey capsid-specific positive control cells for IFNγ ELISpot assays for adeno-associated gene therapy applications

为腺相关基因治疗应用生成食蟹猴衣壳特异性阳性对照细胞,用于IFNγ ELISpot检测

2025-12-311
PRE
Correction: Longitudinal evaluation of serum neurofilament light levels in normal healthy volunteers: defining a threshold of concern

更正:对正常健康志愿者血清神经丝蛋白轻链水平的纵向评估:确定一个值得关注阈值

2025-10-290
OA
Longitudinal evaluation of serum neurofilament light levels in normal healthy volunteers: defining a threshold of concern

纵向评估正常健康志愿者血清神经丝蛋白轻链水平:确定一个关注阈值

2025-07-150
OAAI
Transcriptomic and proteomic characterization of cell and protein biomarkers of checkpoint inhibitor-induced liver injury

转录组学和蛋白质组学表征检查点抑制剂诱导的肝脏损伤的细胞和蛋白质生物标志物

2025-05-030
OA
A Novel C-C Chemoattractant Cytokine (Chemokine) Receptor 6 (CCR6) Antagonist (PF-07054894) Distinguishes between Homologous Chemokine Receptors, Increases Basal Circulating CCR6+T Cells, and Ameliorates Interleukin-23-Induced Skin Inflammation
2023-07-018
OAAI
An Assessment of LRRK2 Serine 935 Phosphorylation in Human Peripheral Blood Mononuclear Cells in Idiopathic Parkinson?s Disease and G2019S LRRK2 Cohorts
2020-04-0334
OAAI
LRRK2 activation in idiopathic Parkinson's disease
2018-07-25362
OAAI